Gilead Sciences Inc. (GILD) News Headlines

▮ More

Date

Headline

9/16/2022 7:30:37 AM Gilead: Kite's CAR T-cell Therapy Yescarta Gets Positive Opinion From CHMP In EU

9/16/2022 7:13:52 AM Gilead Sciences Says CHMP Adopts Positive Opinion To Extend Indication Of Veklury

9/16/2022 7:03:31 AM Kite Says EMA Committee For Medicinal Products For Human Use Issues Positive Opinion For Yescarta

9/16/2022 6:52:51 AM Gilead Sciences: CHMP Adopts Positive Opinion To Extend Indication Of Veklury For Pediatric Patients With COVID-19

9/15/2022 9:27:44 PM Gilead Sciences : WHO Expands Recommendation For Veklury To Patients With Severe COVID-19

9/12/2022 10:50:55 AM Gilead Sciences Gains On Agreement With Generic Manufacturers

8/22/2022 2:08:16 AM Gilead's Twice-yearly HIV Drug Sunlenca Gets European Commission Approval

8/22/2022 1:03:36 AM Gilead Sciences Says European Commission Grants Marketing Authorization For Sunlenca

8/17/2022 12:05:22 PM Gilead Sciences Collaborates With Morehouse School Of Medicine, Xavier University Of Louisiana College Of Pharmacy

8/15/2022 9:02:40 PM Gilead Sciences To Buy Remaining Worldwide Rights Of Trodelvy

8/15/2022 7:47:20 PM Gilead To Acquire Remaining Worldwide Rights Of Trodelvy

8/15/2022 8:48:43 AM Gilead: Phase 3 TROPiCS-02 Study With Trodelvy Shows Clinically Meaningful Survival Results

8/15/2022 8:36:39 AM Gilead :Trodelvy Improves Overall Survival In Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients In Phase 3 Study

8/4/2022 8:24:48 AM Gilead Sciences To Buy Clinical-stage Private Biotechnology Firm MiroBio For $405 Mln In Cash

8/4/2022 8:03:53 AM Gilead To Buy MiroBio For About $405 Mln Cash

8/2/2022 9:19:03 PM Gilead Sciences Q2 Profit Down; Lifts FY Adj. Profit, Total Product Sales Outlook

8/2/2022 5:18:47 PM Gilead Sciences Inc. (GILD) Has Raised Its FY22 Revenue Estimate To $24.5 - $25.0 Bln From $23.8 - $24.3 Bln

8/2/2022 5:17:59 PM Gilead Sciences Inc. (GILD) Has Raised Its FY22 EPS Estimate To 6.30 - 6.75 From 6.20 - 6.70

8/2/2022 5:14:49 PM Gilead Sciences Inc. (GILD) Declares Quarterly Dividend of $ 0.73, Record Date 9/15/2022

8/2/2022 5:08:25 PM Gilead Sciences Q2 EPS $0.91 Vs. $1.21 Year Ago